Many physicians would switch migraine patients from oral treatments if the same drugs were available as a nasal inhalation, topical, or transdermal patch according to a new report.
US demand for drug delivery systems is set to increase by over 10
per cent a year, reaching $132bn in 2012 with growth driven by
injectable biologic dugs, according to a new study by the Freedonia
Group.
A group of US researchers claim to have identified a fundamental
mechanism that may facilitate the design of safer and more
efficacious topical drug delivery systems, reports Phil
Taylor.
